Harmeet Singh Sachdev, MD
Neurology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 25
- 5 carriers
- Office
- 1
Offices
1 location · Harmeet S Sachdev MD Inc · 2 clinicians in this group
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
25 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sachdev’s office at (405) 358-7314 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A32130 · Current
Licensed to practise in California · since 1978 · expires 2028-01-31 · Punjab University, Government Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$336,985
Medicare paid this office $336,985 for 445 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Measurement of brain wave activity (eeg), awake and asleep | 228 | $103,485 | $450 |
| Complete ultrasound of within the brain blood flow | 270 | $56,982 | $206 |
| Long return visit (40+ min) | 203 | $48,331 | $150 |
| Ultrasound of within the brain blood flow for blood clots | 270 | $41,429 | $150 |
| Measurement of brain wave activity (eeg), awake and drowsy | 70 | $27,593 | $389 |
See all 12 services
| Measurement of brain wave activity (eeg), awake and asleep | 228 | $103,485 | $450 |
| Complete ultrasound of within the brain blood flow | 270 | $56,982 | $206 |
| Long return visit (40+ min) | 203 | $48,331 | $150 |
| Ultrasound of within the brain blood flow for blood clots | 270 | $41,429 | $150 |
| Measurement of brain wave activity (eeg), awake and drowsy | 70 | $27,593 | $389 |
| Measurement of brain wave activity (eeg), 12-26 hours | 30 | $17,690 | $295 |
| Measurement of brain wave activity (eeg), continuous | 30 | $8,387 | $262 |
| Return visit (30+ min) | 60 | $7,748 | $112 |
| Measurement of brain wave activity (eeg), 37-60 hours with health care professional review and report | 29 | $5,164 | $178 |
| New patient visit (60+ min) | 23 | $3,940 | $171 |
| Administration of psychological or neuropsychological test, first 30 minutes | 70 | $2,631 | $36 |
| Administration of psychological or neuropsychological test, each additional 30 minutes | 70 | $2,439 | $33 |
Who their Medicare patients are
445 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 20% · Women 54% · Also on Medicaid 4% · Health risk score 1.54. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Stroke 59% · Coronary heart disease 40% · Diabetes 36% · Dementia 31% · Atrial fibrillation 30% · Chronic kidney disease 25% · Depression 21% · Heart failure 20% · Cancer 19% · COPD 12%.
The office billed $763,403, Medicare allowed $438,072 and paid $336,985; for 1,622 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 445 | 1,622 | 78 | 1.54 | $763,403 | $336,985 |
| 2023 | 552 | 2,546 | 78 | 1.51 | $924,170 | $472,997 |
| 2022 | 625 | 2,781 | 77 | 1.57 | $952,954 | $506,349 |
| 2021 | 649 | 2,878 | 78 | 1.57 | $978,770 | $567,678 |
| 2020 | 663 | 2,558 | 77 | 1.65 | $834,385 | $434,669 |
| 2019 | 740 | 3,307 | 77 | 1.63 | $1,043,415 | $549,462 |
| 2018 | 738 | 3,007 | 77 | 1.73 | $942,690 | $475,548 |
| 2017 | 688 | 2,888 | 77 | 1.65 | $907,940 | $456,904 |
| 2016 | 675 | 2,744 | 76 | 1.60 | $912,625 | $465,696 |
| 2015 | 668 | 2,832 | 75 | 1.67 | $902,875 | $486,075 |
| 2014 | 662 | 2,747 | 74 | 1.45 | $875,145 | $468,804 |
| 2013 | 593 | 2,152 | 75 | 1.55 | $650,015 | $342,828 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Measurement of brain wave activity (eeg), awake and asleep | 231 | $114,471 | $477 |
| Long return visit (40+ min) | 314 | $74,431 | $160 |
| Complete ultrasound of within the brain blood flow | 274 | $62,961 | $225 |
| Ultrasound of within the brain blood flow for blood clots | 272 | $47,660 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $42,340 | $107 |
| Measurement of brain wave activity (eeg), in coma or asleep | 69 | $30,264 | $439 |
| Critical care, first 30-74 minutes | 30 | $28,005 | $188 |
| Muscle electrical test | 36 | $9,779 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $9,689 | $156 |
| Return visit (30+ min) | 68 | $8,703 | $119 |
| Measurement of brain wave activity (eeg), 12-26 hours | 11 | $6,941 | $316 |
| New patient visit (60+ min) | 38 | $6,914 | $182 |
| Nerve test | 20 | $4,948 | $247 |
| Nerve test | 16 | $4,559 | $285 |
| Administration of psychological or neuropsychological test, first 30 minutes | 92 | $3,914 | $41 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 60 | $3,779 | $56 |
| Administration of psychological or neuropsychological test, each additional 30 minutes | 93 | $3,687 | $38 |
| Measurement of brain wave activity (eeg), 37-60 hours with health care professional review and report | 11 | $2,085 | $190 |
| Critical care, each additional 30 minutes | 15 | $1,697 | $94 |
| Measurement of brain wave activity (eeg), in coma or asleep | 11 | $730 | $52 |
2022: 18 services
| Measurement of brain wave activity (eeg), awake and asleep | 193 | $92,825 | $481 |
| Long return visit (40+ min) | 374 | $81,849 | $164 |
| Complete ultrasound of within the brain blood flow | 258 | $59,607 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 138 | $54,035 | $93 |
| Critical care, first 30-74 minutes | 56 | $51,950 | $193 |
| Ultrasound of within the brain blood flow for blood clots | 254 | $44,847 | $176 |
| Measurement of brain wave activity (eeg), in coma or asleep | 97 | $42,574 | $439 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 112 | $21,597 | $178 |
| New patient visit (60+ min) | 65 | $13,229 | $204 |
| Return visit (30+ min) | 70 | $8,994 | $122 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 74 | $4,816 | $60 |
| Muscle electrical test | 18 | $4,585 | $104 |
| Critical care, each additional 30 minutes | 28 | $3,598 | $97 |
| Nerve test | 13 | $3,294 | $253 |
| Administration of psychological or neuropsychological test, first 30 minutes | 44 | $1,962 | $43 |
| Administration of psychological or neuropsychological test, each additional 30 minutes | 43 | $1,758 | $39 |
| Measurement of brain wave activity (eeg), in coma or asleep | 26 | $1,497 | $53 |
| Evaluation of neuropsychological test, first hour | 11 | $1,459 | $122 |
2021: 20 services
| Measurement of brain wave activity (eeg), awake and asleep | 235 | $119,008 | $498 |
| Long return visit (40+ min) | 409 | $105,540 | $164 |
| Complete ultrasound of within the brain blood flow | 322 | $76,758 | $238 |
| Ultrasound of within the brain blood flow for blood clots | 313 | $55,063 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 127 | $51,386 | $94 |
| Critical care, first 30-74 minutes | 54 | $45,363 | $197 |
| Measurement of brain wave activity (eeg), in coma or asleep | 83 | $37,403 | $451 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 106 | $20,141 | $183 |
| New patient visit (60+ min) | 82 | $17,049 | $208 |
| Measurement of brain wave activity (eeg), 12-26 hours | 15 | $9,183 | $317 |
| Return visit (30+ min) | 72 | $8,942 | $116 |
| Telephone medical discussion with physician, 21-30 minutes | 31 | $4,792 | $126 |
| Measurement of brain wave activity (eeg), continuous | 13 | $3,724 | $286 |
| Measurement of brain wave activity (eeg), 37-60 hours with health care professional review and report | 14 | $2,753 | $197 |
| Short return visit (20+ min) | 14 | $1,338 | $89 |
| Critical care, each additional 30 minutes | 11 | $1,288 | $99 |
| Administration of psychological or neuropsychological test, first 30 minutes | 21 | $971 | $46 |
| Measurement of brain wave activity (eeg), in coma or asleep | 17 | $926 | $54 |
| Administration of psychological or neuropsychological test, each additional 30 minutes | 21 | $884 | $42 |
| Measurement of brain wave activity (eeg), awake and asleep | 12 | $654 | $54 |
2020: 14 services
| Measurement of brain wave activity (eeg), awake and asleep | 242 | $106,696 | $439 |
| Long return visit (40+ min) | 433 | $81,978 | $122 |
| Complete ultrasound of within the brain blood flow | 272 | $58,052 | $213 |
| Ultrasound of within the brain blood flow for blood clots | 262 | $44,350 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 110 | $39,068 | $91 |
| Critical care, first 30-74 minutes | 38 | $28,278 | $190 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 106 | $20,489 | $177 |
| New patient visit (60+ min) | 94 | $17,009 | $181 |
| Measurement of brain wave activity (eeg), in coma or asleep | 36 | $14,352 | $399 |
| Return visit (30+ min) | 122 | $11,656 | $88 |
| Telephone medical discussion with physician, 21-30 minutes | 37 | $3,272 | $84 |
| Critical care, each additional 30 minutes | 13 | $1,422 | $95 |
| Administration of psychological or neuropsychological test, first 30 minutes | 26 | $1,116 | $43 |
| Administration of psychological or neuropsychological test, each additional 30 minutes | 26 | $1,037 | $40 |
2019: 14 services
| Measurement of brain wave activity (eeg), awake and asleep | 261 | $112,784 | $427 |
| Long return visit (40+ min) | 470 | $88,402 | $123 |
| Complete ultrasound of within the brain blood flow | 357 | $77,350 | $217 |
| Ultrasound of within the brain blood flow for blood clots | 332 | $57,475 | $166 |
| Critical care, first 30-74 minutes | 114 | $56,580 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 143 | $43,643 | $89 |
| Return visit (30+ min) | 322 | $36,960 | $94 |
| Measurement of brain wave activity (eeg), in coma or asleep | 54 | $21,062 | $390 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $18,059 | $174 |
| New patient visit (60+ min) | 83 | $15,103 | $182 |
| Critical care, each additional 30 minutes | 47 | $5,729 | $94 |
| Measurement of brain wave activity (eeg), awake and asleep | 42 | $2,197 | $51 |
| Administration of psychological or neuropsychological test, first 30 minutes | 22 | $968 | $44 |
| Administration of psychological or neuropsychological test, each additional 30 minutes | 22 | $908 | $41 |
2018: 13 services
| Measurement of brain wave activity (eeg), awake and asleep | 235 | $98,732 | $420 |
| Long return visit (40+ min) | 426 | $77,221 | $119 |
| Complete ultrasound of within the brain blood flow | 340 | $53,216 | $156 |
| Ultrasound of within the brain blood flow for blood clots | 300 | $51,328 | $171 |
| Critical care, first 30-74 minutes | 90 | $49,614 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 147 | $37,795 | $88 |
| Return visit (30+ min) | 265 | $31,071 | $91 |
| Measurement of brain wave activity (eeg), in coma or asleep | 73 | $26,418 | $362 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 104 | $18,319 | $171 |
| New patient visit (60+ min) | 85 | $15,231 | $179 |
| Critical care, each additional 30 minutes | 35 | $5,631 | $92 |
| Measurement of brain wave activity (eeg), awake and asleep | 33 | $1,851 | $50 |
| Measurement of brain wave activity (eeg), in coma or asleep | 21 | $1,100 | $50 |
2017: 11 services
| Measurement of brain wave activity (eeg), in coma or asleep | 280 | $103,312 | $364 |
| Complete ultrasound of within the brain blood flow | 353 | $76,177 | $216 |
| Long return visit (40+ min) | 403 | $66,553 | $115 |
| Ultrasound of within the brain blood flow for blood clots | 306 | $51,903 | $170 |
| Critical care, first 30-74 minutes | 86 | $48,270 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 118 | $39,016 | $87 |
| Return visit (30+ min) | 213 | $21,760 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $15,030 | $169 |
| New patient visit (60+ min) | 77 | $13,004 | $169 |
| Critical care, each additional 30 minutes | 65 | $12,191 | $92 |
| Measurement of brain wave activity (eeg), in coma or asleep | 50 | $2,818 | $49 |
2016: 11 services
| Measurement of brain wave activity (eeg), in coma or asleep | 322 | $122,137 | $377 |
| Long return visit (40+ min) | 410 | $71,726 | $125 |
| Complete ultrasound of within the brain blood flow | 355 | $70,833 | $200 |
| Critical care, first 30-74 minutes | 89 | $55,805 | $192 |
| Ultrasound of within the brain blood flow for blood clots | 276 | $41,806 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 117 | $32,303 | $91 |
| New patient visit (60+ min) | 104 | $18,765 | $180 |
| Critical care, each additional 30 minutes | 63 | $17,027 | $96 |
| Return visit (30+ min) | 123 | $12,628 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $11,810 | $176 |
| Measurement of brain wave activity (eeg), in coma or asleep | 44 | $2,319 | $52 |
2015: 12 services
| Measurement of brain wave activity (eeg), in coma or asleep | 301 | $112,393 | $373 |
| Complete ultrasound of within the brain blood flow | 338 | $77,856 | $230 |
| Ultrasound of within the brain blood flow for blood clots | 314 | $61,245 | $195 |
| Critical care, first 30-74 minutes | 98 | $54,143 | $193 |
| Long return visit (40+ min) | 341 | $51,450 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $38,202 | $92 |
| Return visit (30+ min) | 289 | $34,261 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 90 | $16,039 | $178 |
| Critical care, each additional 30 minutes | 74 | $15,379 | $97 |
| New patient visit (60+ min) | 59 | $11,053 | $187 |
| Measurement of brain wave activity (eeg), in coma or asleep | 55 | $3,051 | $52 |
| Complete ultrasound of within the brain blood flow | 12 | $624 | $42 |
2014: 13 services
| Measurement of brain wave activity (eeg), in coma or asleep | 242 | $89,368 | $369 |
| Complete ultrasound of within the brain blood flow | 344 | $83,889 | $244 |
| Critical care, first 30-74 minutes | 113 | $82,879 | $195 |
| Ultrasound of within the brain blood flow for blood clots | 232 | $45,110 | $194 |
| Long return visit (40+ min) | 285 | $39,478 | $123 |
| Return visit (30+ min) | 283 | $37,372 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 135 | $33,271 | $92 |
| Critical care, each additional 30 minutes | 78 | $15,255 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $14,929 | $180 |
| New patient visit (60+ min) | 53 | $9,870 | $186 |
| Measurement of brain wave activity (eeg), in coma or asleep | 68 | $4,020 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,025 | $64 |
| Complete ultrasound of within the brain blood flow | 18 | $876 | $44 |
2013: 13 services
| Critical care, first 30-74 minutes | 98 | $71,580 | $191 |
| Long return visit (40+ min) | 374 | $71,138 | $127 |
| Measurement of brain wave activity (eeg), in coma or asleep | 148 | $64,604 | $431 |
| Complete ultrasound of within the brain blood flow | 252 | $50,550 | $200 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 119 | $31,289 | $89 |
| Ultrasound of within the brain blood flow for blood clots | 97 | $15,077 | $155 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $13,550 | $172 |
| Critical care, each additional 30 minutes | 57 | $7,961 | $96 |
| New patient visit (60+ min) | 24 | $4,357 | $182 |
| Measurement of brain wave activity (eeg), in coma or asleep | 68 | $3,954 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,247 | $62 |
| Return visit (30+ min) | 15 | $1,391 | $93 |
| Complete ultrasound of within the brain blood flow | 21 | $1,021 | $43 |
Drugs they prescribed that Part D paid
$631,653
Pharmacies billed $631,653 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,214) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
1,118 generic and fewer than 11 brand-name prescriptions · $631,653 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Copaxone | 17 | $139,407 | $8,200 |
| Rebif | 13 | $134,517 | $10,347 |
| Teriflunomide | 31 | $76,970 | $2,483 |
| Glatiramer Acetate | 40 | $66,993 | $1,675 |
| Fycompa | 15 | $22,391 | $1,493 |
See all 23 drugs
| Copaxone | 17 | $139,407 | $8,200 |
| Rebif | 13 | $134,517 | $10,347 |
| Teriflunomide | 31 | $76,970 | $2,483 |
| Glatiramer Acetate | 40 | $66,993 | $1,675 |
| Fycompa | 15 | $22,391 | $1,493 |
| Dalfampridine Er | 18 | $10,355 | $575 |
| Brilinta | 22 | $10,235 | $465 |
| Rivastigmine | 33 | $10,044 | $304 |
| Lacosamide | 71 | $9,377 | $132 |
| Memantine | 149 | $5,798 | $39 |
| Lamotrigine | 79 | $2,501 | $32 |
| Gabapentin | 119 | $2,181 | $18 |
| Clopidogrel | 140 | $2,113 | $15 |
| Oxcarbazepine | 23 | $1,867 | $81 |
| Levetiracetam | 74 | $1,799 | $24 |
| Pyridostigmine | 12 | $1,392 | $116 |
| Rivastigmine | 28 | $1,154 | $41 |
| Donepezil | 41 | $654 | $16 |
| Primidone | 18 | $589 | $33 |
| Amantadine | 14 | $466 | $33 |
| Topiramate | 20 | $440 | $22 |
| Carbidopa-Levodopa | 20 | $363 | $18 |
| Ropinirole | 13 | $111 | $9 |
Year by year
| 2024 | 1,214 | 236 | 0% (0) | None | $631,653 |
| 2023 | 1,604 | 248 | 0% (0) | None | $1,086,845 |
| 2022 | 1,760 | 270 | None | 15% | $1,648,652 |
| 2021 | 2,066 | 302 | None | 19% | $1,785,143 |
| 2020 | 2,100 | 306 | 1% (11) | 22% | $2,036,122 |
| 2019 | 2,046 | 298 | None | None | $1,888,159 |
| 2018 | 1,726 | 251 | 0% (0) | None | $1,679,079 |
| 2017 | 1,527 | 232 | None | None | $1,274,430 |
| 2016 | 1,417 | 226 | None | None | $1,375,768 |
| 2015 | 1,384 | 210 | 2% (27) | None | $1,183,112 |
| 2014 | 1,408 | 191 | 2% (30) | None | $763,011 |
| 2013 | 1,311 | 164 | 1% (17) | None | $618,809 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Glatiramer Acetate | 48 | $224,365 | $4,674 |
| Copaxone | 22 | $176,570 | $8,026 |
| Aubagio | 13 | $165,858 | $12,758 |
| Rebif | 13 | $139,876 | $10,760 |
| Teriflunomide | 11 | $54,658 | $4,969 |
| Rivastigmine | 127 | $43,770 | $345 |
| Fycompa | 20 | $22,646 | $1,132 |
| Dalfampridine Er | 34 | $17,808 | $524 |
| Brilinta | 29 | $15,793 | $545 |
| Lacosamide | 95 | $11,401 | $120 |
| Memantine | 172 | $10,248 | $60 |
| Levetiracetam | 88 | $4,170 | $47 |
| Lamotrigine | 106 | $3,787 | $36 |
| Carbamazepine Er | 11 | $3,445 | $313 |
| Gabapentin | 150 | $3,407 | $23 |
| Clopidogrel | 166 | $2,707 | $16 |
| Oxcarbazepine | 23 | $2,592 | $113 |
| Rivastigmine | 48 | $2,294 | $48 |
| Memantine Hcl Er | 11 | $1,626 | $148 |
| Carbidopa-Levodopa | 38 | $1,411 | $37 |
| Primidone | 19 | $1,225 | $64 |
| Donepezil | 52 | $1,209 | $23 |
| Topiramate | 21 | $1,190 | $57 |
| Amantadine | 16 | $924 | $58 |
| Baclofen | 16 | $413 | $26 |
| Bupropion | 14 | $177 | $13 |
| Trazodone | 18 | $151 | $8 |
| Zolpidem | 12 | $114 | $10 |
| Cyclobenzaprine | 13 | $63 | $5 |
2022: 32 drugs
| Aubagio | 35 | $509,435 | $14,555 |
| Copaxone | 29 | $231,292 | $7,976 |
| Glatiramer Acetate | 52 | $224,057 | $4,309 |
| Rebif | 12 | $120,370 | $10,031 |
| Vimpat | 72 | $90,478 | $1,257 |
| Avonex | 11 | $89,916 | $8,174 |
| Rivastigmine | 156 | $52,149 | $334 |
| Fycompa | 19 | $17,191 | $905 |
| Lacosamide | 39 | $15,270 | $392 |
| Dalfampridine Er | 46 | $14,479 | $315 |
| Brilinta | 16 | $13,247 | $828 |
| Rasagiline Mesylate | 27 | $12,872 | $477 |
| Memantine | 151 | $9,271 | $61 |
| Levetiracetam | 128 | $4,638 | $36 |
| Gabapentin | 133 | $3,514 | $26 |
| Lamotrigine | 99 | $3,431 | $35 |
| Oxcarbazepine | 27 | $3,322 | $123 |
| Clopidogrel | 160 | $2,425 | $15 |
| Amantadine | 20 | $2,371 | $119 |
| Carbidopa-Levodopa | 38 | $2,226 | $59 |
| Rivastigmine | 40 | $2,004 | $50 |
| Donepezil | 70 | $1,512 | $22 |
| Baclofen | 24 | $1,062 | $44 |
| Primidone | 13 | $883 | $68 |
| Topiramate | 16 | $859 | $54 |
| Ropinirole | 13 | $489 | $38 |
| Carbidopa-Levodopa Er | 11 | $303 | $28 |
| Pregabalin | 11 | $222 | $20 |
| Bupropion | 13 | $200 | $15 |
| Verapamil | 13 | $172 | $13 |
| Lorazepam | 22 | $151 | $7 |
| Zolpidem | 11 | $111 | $10 |
2021: 38 drugs
| Aubagio | 53 | $540,638 | $10,201 |
| Copaxone | 33 | $243,914 | $7,391 |
| Glatiramer Acetate | 42 | $185,014 | $4,405 |
| Vimpat | 156 | $142,347 | $912 |
| Rebif | 12 | $116,114 | $9,676 |
| Avonex | 11 | $86,613 | $7,874 |
| Rivastigmine | 133 | $39,777 | $299 |
| Brilinta | 40 | $21,699 | $542 |
| Dalfampridine Er | 40 | $19,817 | $495 |
| Fycompa | 15 | $12,086 | $806 |
| Rasagiline Mesylate | 25 | $10,723 | $429 |
| Memantine | 153 | $9,067 | $59 |
| Levetiracetam | 150 | $6,205 | $41 |
| Memantine Hcl Er | 16 | $4,148 | $259 |
| Lamotrigine | 87 | $3,717 | $43 |
| Oxcarbazepine | 29 | $3,355 | $116 |
| Gabapentin | 131 | $3,237 | $25 |
| Carbidopa-Levodopa | 39 | $2,889 | $74 |
| Clopidogrel | 159 | $2,565 | $16 |
| Pyridostigmine | 16 | $2,376 | $148 |
| Amantadine | 33 | $2,250 | $68 |
| Donepezil | 118 | $2,202 | $19 |
| Verapamil Er | 26 | $1,569 | $60 |
| Primidone | 17 | $1,171 | $69 |
| Baclofen | 30 | $1,064 | $35 |
| Pregabalin | 15 | $1,015 | $68 |
| Rivastigmine | 21 | $903 | $43 |
| Topiramate | 18 | $834 | $46 |
| Phenobarbital | 12 | $831 | $69 |
| Clonazepam | 25 | $734 | $29 |
| Carbidopa-Levodopa Er | 14 | $555 | $40 |
| Bupropion | 13 | $373 | $29 |
| Risperidone | 27 | $327 | $12 |
| Verapamil | 14 | $284 | $20 |
| Escitalopram | 17 | $208 | $12 |
| Duloxetine | 14 | $154 | $11 |
| Lorazepam | 25 | $114 | $5 |
| Diazepam | 22 | $44 | $2 |
2020: 49 drugs
| Aubagio | None | 66 | $537,757 | $8,148 |
| Copaxone | None | 43 | $320,084 | $7,444 |
| Tecfidera | None | 31 | $260,336 | $8,398 |
| Glatiramer Acetate | None | 38 | $153,700 | $4,045 |
| Vimpat | None | 135 | $131,504 | $974 |
| Dalfampridine Er | None | 42 | $42,097 | $1,002 |
| Rivastigmine | None | 72 | $25,845 | $359 |
| Rasagiline Mesylate | None | 41 | $24,293 | $593 |
| Brilinta | None | 48 | $21,260 | $443 |
| Oxtellar Xr | None | 15 | $19,169 | $1,278 |
| Fycompa | None | 16 | $12,508 | $782 |
| Aimovig | Migraine | 15 | $10,013 | $668 |
| Memantine | None | 128 | $8,761 | $68 |
| Carbamazepine Er | None | 11 | $4,892 | $445 |
| Levetiracetam | None | 122 | $4,293 | $35 |
| Donepezil | None | 157 | $4,063 | $26 |
| Lamotrigine | None | 71 | $3,601 | $51 |
| Carbidopa-Levodopa | None | 69 | $3,302 | $48 |
| Oxcarbazepine | None | 19 | $3,143 | $165 |
| Gabapentin | None | 111 | $2,894 | $26 |
| Memantine Hcl Er | None | 18 | $2,676 | $149 |
| Pyridostigmine | None | 12 | $2,555 | $213 |
| Clopidogrel | None | 147 | $2,088 | $14 |
| Propranolol Hcl Er | None | 15 | $1,972 | $131 |
| Phenytoin Sodium Extended | None | 14 | $1,620 | $116 |
| Primidone | None | 19 | $1,401 | $74 |
| Pregabalin | None | 17 | $1,338 | $79 |
| Verapamil Er | None | 20 | $1,231 | $62 |
| Propranolol | None | 30 | $952 | $32 |
| Baclofen | None | 26 | $762 | $29 |
| Phenobarbital | None | 15 | $715 | $48 |
| Amantadine | None | 19 | $657 | $35 |
| Clonazepam | None | 22 | $608 | $28 |
| Topiramate | None | 28 | $469 | $17 |
| Nadolol | None | 11 | $442 | $40 |
| Quetiapine | None | 30 | $420 | $14 |
| Nortriptyline | None | 21 | $418 | $20 |
| Bupropion | None | 17 | $375 | $22 |
| Ropinirole | None | 11 | $237 | $22 |
| Zolpidem | None | 12 | $212 | $18 |
| Lorazepam | None | 30 | $189 | $6 |
| Risperidone | None | 12 | $182 | $15 |
| Prednisone | None | 17 | $176 | $10 |
| Verapamil | None | 13 | $152 | $12 |
| Atorvastatin | None | 11 | $148 | $13 |
| Amitriptyline | None | 12 | $123 | $10 |
| Duloxetine | None | 13 | $123 | $9 |
| Escitalopram | None | 16 | $112 | $7 |
| Diazepam | None | 18 | $76 | $4 |
2019: 47 drugs
| Copaxone | 56 | $471,189 | $8,414 |
| Aubagio | 39 | $281,938 | $7,229 |
| Tecfidera | 24 | $205,477 | $8,562 |
| Glatiramer Acetate | 28 | $132,158 | $4,720 |
| Vimpat | 106 | $112,747 | $1,064 |
| Rasagiline Mesylate | 82 | $26,996 | $329 |
| Dalfampridine Er | 34 | $24,746 | $728 |
| Rivastigmine | 51 | $21,418 | $420 |
| Oxtellar Xr | 29 | $16,907 | $583 |
| Lyrica | 31 | $16,150 | $521 |
| Pyridostigmine Bromide Er | 21 | $11,007 | $524 |
| Brilinta | 29 | $10,935 | $377 |
| Memantine | 104 | $7,887 | $76 |
| Tegretol Xr | 13 | $7,628 | $587 |
| Exelon | 11 | $7,541 | $686 |
| Lamotrigine | 73 | $4,196 | $57 |
| Carbamazepine Er | 12 | $3,974 | $331 |
| Levetiracetam | 113 | $3,829 | $34 |
| Gabapentin | 103 | $3,807 | $37 |
| Donepezil | 187 | $3,332 | $18 |
| Memantine Hcl Er | 12 | $3,123 | $260 |
| Pyridostigmine | 15 | $2,616 | $174 |
| Carbidopa-Levodopa | 64 | $2,175 | $34 |
| Amantadine | 28 | $1,963 | $70 |
| Clopidogrel | 118 | $1,807 | $15 |
| Propranolol Hcl Er | 20 | $1,581 | $79 |
| Verapamil Sr | 16 | $1,533 | $96 |
| Phenytoin Sodium Extended | 11 | $1,272 | $116 |
| Oxcarbazepine | 14 | $987 | $70 |
| Topiramate | 44 | $904 | $21 |
| Primidone | 26 | $751 | $29 |
| Clonazepam | 35 | $748 | $21 |
| Nadolol | 12 | $711 | $59 |
| Propranolol | 27 | $588 | $22 |
| Baclofen | 22 | $469 | $21 |
| Sumatriptan | 16 | $409 | $26 |
| Ropinirole | 14 | $362 | $26 |
| Quetiapine | 32 | $352 | $11 |
| Bupropion | 16 | $280 | $18 |
| Escitalopram | 18 | $275 | $15 |
| Lorazepam | 28 | $267 | $10 |
| Verapamil Er | 13 | $222 | $17 |
| Zolpidem | 15 | $167 | $11 |
| Prednisone | 13 | $146 | $11 |
| Verapamil | 18 | $134 | $7 |
| Duloxetine | 12 | $115 | $10 |
| Diazepam | 13 | $34 | $3 |
2018: 38 drugs
| Copaxone | 83 | $644,702 | $7,767 |
| Tecfidera | 20 | $202,986 | $10,149 |
| Vimpat | 85 | $108,461 | $1,276 |
| Rebif | 11 | $101,796 | $9,254 |
| Avonex | 14 | $96,975 | $6,927 |
| Ampyra | 25 | $83,096 | $3,324 |
| Aubagio | 11 | $72,360 | $6,578 |
| Rasagiline Mesylate | 61 | $34,614 | $567 |
| Exelon | 22 | $20,558 | $934 |
| Oxtellar Xr | 29 | $14,751 | $509 |
| Lyrica | 26 | $13,600 | $523 |
| Rivastigmine | 28 | $8,904 | $318 |
| Memantine | 91 | $7,577 | $83 |
| Lamotrigine | 76 | $3,725 | $49 |
| Amantadine | 29 | $2,980 | $103 |
| Levetiracetam | 114 | $2,804 | $25 |
| Gabapentin | 70 | $2,799 | $40 |
| Donepezil | 187 | $2,746 | $15 |
| Carbidopa-Levodopa | 57 | $2,642 | $46 |
| Lamotrigine Er | 18 | $2,522 | $140 |
| Verapamil Sr | 16 | $2,332 | $146 |
| Clopidogrel | 113 | $1,861 | $16 |
| Propranolol Hcl Er | 18 | $1,771 | $98 |
| Nadolol | 16 | $1,360 | $85 |
| Phenytoin Sodium Extended | 14 | $1,264 | $90 |
| Topiramate | 32 | $798 | $25 |
| Primidone | 22 | $797 | $36 |
| Clonazepam | 39 | $601 | $15 |
| Baclofen | 17 | $601 | $35 |
| Propranolol | 23 | $580 | $25 |
| Carbidopa-Levodopa Er | 12 | $541 | $45 |
| Divalproex Sodium Er | 12 | $520 | $43 |
| Verapamil Er | 13 | $302 | $23 |
| Escitalopram | 15 | $245 | $16 |
| Quetiapine | 28 | $230 | $8 |
| Bupropion | 11 | $228 | $21 |
| Lorazepam | 22 | $222 | $10 |
| Ropinirole | 14 | $138 | $10 |
2017: 37 drugs
| Copaxone | 89 | $647,427 | $7,274 |
| Rebif | 12 | $87,263 | $7,272 |
| Vimpat | 62 | $59,735 | $963 |
| Ampyra | 15 | $48,222 | $3,215 |
| Rasagiline Mesylate | 33 | $25,783 | $781 |
| Exelon | 25 | $16,013 | $641 |
| Lyrica | 29 | $14,930 | $515 |
| Trokendi Xr | 17 | $9,279 | $546 |
| Migergot | 12 | $9,093 | $758 |
| Oxtellar Xr | 25 | $8,789 | $352 |
| Memantine | 73 | $7,666 | $105 |
| Namenda Xr | 15 | $5,862 | $391 |
| Rivastigmine | 15 | $5,315 | $354 |
| Amantadine | 16 | $3,250 | $203 |
| Lamotrigine | 103 | $3,010 | $29 |
| Gabapentin | 75 | $2,916 | $39 |
| Clopidogrel | 123 | $2,738 | $22 |
| Levetiracetam | 113 | $2,638 | $23 |
| Carbidopa-Levodopa | 60 | $2,550 | $43 |
| Propranolol Hcl Er | 14 | $2,089 | $149 |
| Pyridostigmine | 14 | $1,810 | $129 |
| Divalproex Sodium Er | 16 | $1,692 | $106 |
| Phenytoin Sodium Extended | 23 | $1,627 | $71 |
| Lamotrigine Er | 14 | $1,351 | $97 |
| Donepezil | 98 | $934 | $10 |
| Oxcarbazepine | 13 | $868 | $67 |
| Carbidopa-Levodopa Er | 19 | $824 | $43 |
| Nadolol | 11 | $663 | $60 |
| Propranolol | 28 | $654 | $23 |
| Topiramate | 28 | $569 | $20 |
| Primidone | 16 | $452 | $28 |
| Ropinirole | 12 | $335 | $28 |
| Clonazepam | 26 | $303 | $12 |
| Escitalopram | 16 | $296 | $18 |
| Lorazepam | 23 | $225 | $10 |
| Sumatriptan | 13 | $208 | $16 |
| Alprazolam | 12 | $115 | $10 |
2016: 35 drugs
| Copaxone | 97 | $685,991 | $7,072 |
| Rebif | 24 | $183,364 | $7,640 |
| Tecfidera | 13 | $115,173 | $8,859 |
| Ampyra | 11 | $52,652 | $4,787 |
| Vimpat | 49 | $46,199 | $943 |
| Azilect | 32 | $39,213 | $1,225 |
| Exelon | 44 | $23,989 | $545 |
| Lyrica | 24 | $10,297 | $429 |
| Namenda Xr | 21 | $9,347 | $445 |
| Rivastigmine | 17 | $8,183 | $481 |
| Oxtellar Xr | 19 | $6,275 | $330 |
| Memantine | 41 | $3,676 | $90 |
| Amantadine | 12 | $3,282 | $274 |
| Dilantin | 22 | $3,174 | $144 |
| Divalproex Sodium Er | 13 | $2,824 | $217 |
| Clopidogrel | 106 | $2,749 | $26 |
| Pyridostigmine | 16 | $2,729 | $171 |
| Lamotrigine | 93 | $2,697 | $29 |
| Gabapentin | 70 | $2,648 | $38 |
| Propranolol Hcl Er | 19 | $2,402 | $126 |
| Levetiracetam | 65 | $2,021 | $31 |
| Carbidopa-Levodopa | 55 | $1,802 | $33 |
| Phenytoin Sodium Extended | 32 | $1,513 | $47 |
| Clonazepam | 25 | $866 | $35 |
| Carbidopa-Levodopa Er | 16 | $724 | $45 |
| Oxcarbazepine | 14 | $708 | $51 |
| Topiramate | 29 | $586 | $20 |
| Donepezil | 58 | $578 | $10 |
| Sumatriptan | 18 | $465 | $26 |
| Baclofen | 12 | $439 | $37 |
| Propranolol | 11 | $384 | $35 |
| Primidone | 15 | $337 | $22 |
| Lorazepam | 24 | $201 | $8 |
| Escitalopram | 18 | $196 | $11 |
| Bupropion | 11 | $124 | $11 |
2015: 34 drugs
| Copaxone | 65 | $464,882 | $7,152 |
| Tecfidera | 26 | $188,366 | $7,245 |
| Rebif | 21 | $172,168 | $8,198 |
| Ampyra | 13 | $44,987 | $3,461 |
| Azilect | 41 | $44,926 | $1,096 |
| Vimpat | 28 | $24,294 | $868 |
| Exelon | 24 | $13,312 | $555 |
| Lyrica | 34 | $8,738 | $257 |
| Divalproex Sodium Er | 13 | $4,440 | $342 |
| Dilantin | 36 | $3,011 | $84 |
| Clopidogrel | 119 | $2,856 | $24 |
| Levetiracetam | 97 | $2,823 | $29 |
| Gabapentin | 85 | $2,742 | $32 |
| Oxtellar Xr | 14 | $2,477 | $177 |
| Propranolol Hcl Er | 12 | $1,929 | $161 |
| Carbidopa-Levodopa | 53 | $1,922 | $36 |
| Lamotrigine | 65 | $1,795 | $28 |
| Phenytoin Sodium Extended | 38 | $1,735 | $46 |
| Butalbital-Acetaminophen-Caffe | 15 | $1,392 | $93 |
| Lamotrigine Er | 12 | $1,236 | $103 |
| Oxcarbazepine | 20 | $1,058 | $53 |
| Topiramate | 48 | $875 | $18 |
| Primidone | 26 | $700 | $27 |
| Donepezil | 29 | $442 | $15 |
| Baclofen | 18 | $439 | $24 |
| Quetiapine | 16 | $420 | $26 |
| Clonazepam | 32 | $390 | $12 |
| Ropinirole | 13 | $320 | $25 |
| Acetaminophen-Codeine | 14 | $316 | $23 |
| Lorazepam | 51 | $272 | $5 |
| Sumatriptan | 23 | $237 | $10 |
| Escitalopram | 14 | $163 | $12 |
| Prednisone | 11 | $85 | $8 |
| Zolpidem | 14 | $77 | $6 |
2014: 35 drugs
| Copaxone | 58 | $368,976 | $6,362 |
| Rebif | 18 | $89,693 | $4,983 |
| Aubagio | 11 | $54,041 | $4,913 |
| Azilect | 43 | $31,669 | $736 |
| Vimpat | 41 | $27,063 | $660 |
| Aggrenox | 18 | $10,230 | $568 |
| Clopidogrel | 127 | $5,208 | $41 |
| Lyrica | 12 | $3,922 | $327 |
| Gabapentin | 87 | $3,700 | $43 |
| Divalproex Sodium Er | 12 | $3,196 | $266 |
| Amantadine | 12 | $3,193 | $266 |
| Levetiracetam | 75 | $2,806 | $37 |
| Carbamazepine | 11 | $2,665 | $242 |
| Dilantin | 36 | $2,547 | $71 |
| Lamotrigine | 113 | $2,273 | $20 |
| Propranolol Hcl Er | 12 | $1,899 | $158 |
| Oxtellar Xr | 13 | $1,882 | $145 |
| Oxcarbazepine | 31 | $1,518 | $49 |
| Topiramate | 51 | $1,481 | $29 |
| Phenytoin Sodium Extended | 34 | $1,259 | $37 |
| Carbidopa-Levodopa | 40 | $1,205 | $30 |
| Primidone | 36 | $1,037 | $29 |
| Ropinirole | 13 | $1,019 | $78 |
| Donepezil | 35 | $736 | $21 |
| Requip Xl | 14 | $623 | $45 |
| Clonazepam | 40 | $450 | $11 |
| Hydrocodone-Acetaminophen | 19 | $362 | $19 |
| Quetiapine | 14 | $346 | $25 |
| Baclofen | 11 | $343 | $31 |
| Lorazepam | 55 | $261 | $5 |
| Trihexyphenidyl | 13 | $239 | $18 |
| Atorvastatin | 12 | $222 | $19 |
| Sumatriptan | 11 | $186 | $17 |
| Propranolol | 12 | $100 | $8 |
| Zolpidem | 13 | $77 | $6 |
2013: 34 drugs
| Copaxone | 68 | $342,466 | $5,036 |
| Azilect | 36 | $24,024 | $667 |
| Ampyra | 16 | $23,260 | $1,454 |
| Vimpat | 32 | $17,304 | $541 |
| Lyrica | 15 | $8,042 | $536 |
| Clopidogrel | 105 | $5,811 | $55 |
| Keppra | 11 | $5,809 | $528 |
| Aggrenox | 18 | $5,770 | $321 |
| Gabapentin | 77 | $3,737 | $49 |
| Carbamazepine | 11 | $3,317 | $302 |
| Levetiracetam | 74 | $2,928 | $40 |
| Amantadine | 20 | $2,868 | $143 |
| Lamotrigine | 117 | $2,866 | $24 |
| Dilantin | 38 | $2,592 | $68 |
| Oxcarbazepine | 44 | $1,868 | $42 |
| Primidone | 42 | $1,819 | $43 |
| Topiramate | 34 | $1,689 | $50 |
| Phenytoin Sodium Extended | 34 | $1,338 | $39 |
| Ropinirole | 11 | $1,162 | $106 |
| Propranolol | 34 | $1,148 | $34 |
| Quetiapine | 13 | $1,029 | $79 |
| Carbidopa-Levodopa | 20 | $969 | $48 |
| Donepezil | 33 | $716 | $22 |
| Clonazepam | 39 | $505 | $13 |
| Requip Xl | 12 | $486 | $41 |
| Atorvastatin | 14 | $358 | $26 |
| Lorazepam | 53 | $298 | $6 |
| Divalproex | 15 | $289 | $19 |
| Trihexyphenidyl | 17 | $284 | $17 |
| Fluoxetine | 15 | $182 | $12 |
| Hydrocodone-Acetaminophen | 17 | $165 | $10 |
| Zolpidem | 12 | $71 | $6 |
| Amlodipine Besylate | 12 | $59 | $5 |
| Hydrochlorothiazide | 11 | $37 | $3 |
Money from drug and device companies
$3,142 in 2025
| 2025 | 31 | 132 | $11 | $3,142 |
| 2024 | 33 | 142 | None | $3,662 |
| 2023 | 31 | 149 | None | $3,606 |
| 2022 | 26 | 128 | None | $2,800 |
| 2021 | 32 | 155 | None | $2,993 |
| 2020 | 26 | 77 | None | $1,715 |
| 2019 | 32 | 147 | None | $6,703 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Catalyst Pharmaceuticals | Firdapse | $387 | 21 payments
|
| Alexion Pharmaceuticals | Ultomiris | $301 | 10 payments
|
| Abbvie | Botox | $223 | 10 payments
|
| Lundbeck | Vyepti | $214 | 8 payments
|
| Biogen | Skyclarys | $205 | 11 payments
|
| Novartis Pharmaceuticals | Kesimpta | $198 | 12 payments
|
See all 130 published payments
| Genzyme | Meals · 2025-12-16 | None | $27 |
| Abbvie | Meals · 2025-12-10 | Qulipta | $25 |
| TG Therapeutics | Meals · 2025-12-10 | Briumvi | $17 |
| Ucb | Meals · 2025-12-04 | Nayzilam | $25 |
| Janssen Biotech | Meals · 2025-12-02 | None | $20 |
| Catalyst Pharmaceuticals | Meals · 2025-11-24 | Firdapse | $34 |
| Catalyst Pharmaceuticals | Meals · 2025-11-24 | Firdapse | $4 |
| Catalyst Pharmaceuticals | Meals · 2025-11-17 | Firdapse | $6 |
| Catalyst Pharmaceuticals | Meals · 2025-11-17 | Firdapse | $17 |
| Genzyme | Meals · 2025-11-12 | None | $24 |
| MicroTransponder | Meals · 2025-11-11 | None | $164 |
| TG Therapeutics | Meals · 2025-11-11 | Briumvi | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-11-04 | Rexulti | $23 |
| Amgen | Meals · 2025-10-29 | None | $17 |
| Novartis Pharmaceuticals | Meals · 2025-10-28 | Kesimpta | $25 |
| Janssen Biotech | Meals · 2025-10-27 | None | $24 |
| Genentech USA | Meals · 2025-10-22 | Ocrevus Zunovo | $22 |
| Genzyme | Meals · 2025-10-21 | None | $19 |
| ANI Pharmaceuticals | Meals · 2025-10-20 | Purified Cortrophin Gel | $22 |
| Ucb | Meals · 2025-10-18 | Nayzilam | $30 |
| SK Life Science | Meals · 2025-10-16 | None | $26 |
| Abbvie | Meals · 2025-10-15 | Botox | $28 |
| Novartis Pharmaceuticals | Meals · 2025-10-09 | Kesimpta | $11 |
| Pfizer | Meals · 2025-10-09 | Nurtec Odt | $25 |
| Lundbeck | Meals · 2025-10-01 | Vyepti | $27 |
| Novartis Pharmaceuticals | Meals · 2025-09-29 | Kesimpta | $13 |
| Catalyst Pharmaceuticals | Meals · 2025-09-23 | Firdapse | $28 |
| Catalyst Pharmaceuticals | Meals · 2025-09-22 | Firdapse | $11 |
| Abbvie | Meals · 2025-09-17 | Ubrelvy | $24 |
| Novartis Pharmaceuticals | Meals · 2025-09-15 | Kesimpta | $8 |
| Abbvie | Meals · 2025-09-05 | Botox | $32 |
| Genentech USA | Meals · 2025-09-03 | Ocrevus Zunovo | $26 |
| TG Therapeutics | Meals · 2025-09-02 | Briumvi | $31 |
| Novartis Pharmaceuticals | Meals · 2025-08-25 | Kesimpta | $13 |
| Novartis Pharmaceuticals | Meals · 2025-08-25 | Kesimpta | $11 |
| Neurocrine BioSciences | Meals · 2025-08-22 | Ingrezza | $15 |
| Lundbeck | Meals · 2025-08-20 | Vyepti | $19 |
| Novartis Pharmaceuticals | Meals · 2025-08-19 | Kesimpta | $13 |
| TG Therapeutics | Meals · 2025-08-13 | Briumvi | $41 |
| Axsome Therapeutics | Meals · 2025-08-12 | Symbravo | $25 |
| ANI Pharmaceuticals | Meals · 2025-08-11 | Purified Cortrophin Gel | $27 |
| Novartis Pharmaceuticals | Meals · 2025-08-05 | Kesimpta | $16 |
| Alexion Pharmaceuticals | Meals · 2025-07-30 | Ultomiris | $34 |
| Biogen | Meals · 2025-07-22 | Skyclarys | $25 |
| ANI Pharmaceuticals | Meals · 2025-07-22 | Purified Cortrophin Gel | $25 |
| Catalyst Pharmaceuticals | Meals · 2025-07-22 | Firdapse | $3 |
| Catalyst Pharmaceuticals | Meals · 2025-07-22 | Firdapse | $11 |
| Lilly USA | Meals · 2025-07-18 | Kisunla | $31 |
| Alexion Pharmaceuticals | Meals · 2025-07-15 | Ultomiris | $14 |
| Lundbeck | Meals · 2025-07-11 | Vyepti | $35 |
| CSL Behring | Meals · 2025-07-09 | Hizentra | $36 |
| EMD Serono | Meals · 2025-07-09 | None | $35 |
| MDD US Operations | Paid to speak or teach · 2025-07-08 | None | $11 |
| Neurocrine BioSciences | Meals · 2025-07-03 | Ingrezza | $20 |
| Lundbeck | Meals · 2025-07-03 | Rexulti | $31 |
| Abbvie | Meals · 2025-07-02 | Botox | $4 |
| Abbvie | Meals · 2025-07-02 | Botox | $27 |
| Biogen | Meals · 2025-07-02 | Vumerity | $12 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Kesimpta | $30 |
| Alexion Pharmaceuticals | Meals · 2025-06-25 | Ultomiris | $32 |
| Alexion Pharmaceuticals | Meals · 2025-06-20 | Ultomiris | $32 |
| Neurocrine BioSciences | Meals · 2025-06-13 | Ingrezza | $38 |
| Biogen | Meals · 2025-06-12 | Skyclarys | $28 |
| Novartis Pharmaceuticals | Meals · 2025-06-11 | Kesimpta | $11 |
| Catalyst Pharmaceuticals | Meals · 2025-06-10 | Firdapse | $51 |
| Catalyst Pharmaceuticals | Meals · 2025-06-10 | Firdapse | $4 |
| MDD US Operations | Meals · 2025-06-09 | None | $36 |
| Abbvie | Meals · 2025-06-06 | Botox | $31 |
| Janssen Biotech | Meals · 2025-06-05 | None | $19 |
| Alexion Pharmaceuticals | Meals · 2025-06-04 | Ultomiris | $31 |
| Biogen | Meals · 2025-06-04 | Vumerity | $8 |
| Catalyst Pharmaceuticals | Meals · 2025-05-28 | Firdapse | $35 |
| Catalyst Pharmaceuticals | Meals · 2025-05-28 | Firdapse | $6 |
| Catalyst Pharmaceuticals | Meals · 2025-05-22 | Firdapse | $23 |
| Amneal Pharmaceuticals | Meals · 2025-05-21 | Rytary | $14 |
| Lundbeck | Meals · 2025-05-17 | Vyepti | $18 |
| Celgene | Meals · 2025-05-14 | Zeposia | $19 |
| CSL Behring | Meals · 2025-05-14 | Hizentra | $43 |
| Biogen | Meals · 2025-05-13 | Skyclarys | $20 |
| MDD US Operations | Meals · 2025-05-06 | None | $29 |
| MDD US Operations | Meals · 2025-05-03 | None | $26 |
| Alexion Pharmaceuticals | Meals · 2025-04-30 | Ultomiris | $35 |
| Biogen | Meals · 2025-04-28 | Vumerity | $9 |
| Novartis Pharmaceuticals | Meals · 2025-04-23 | Kesimpta | $32 |
| Celgene | Meals · 2025-04-17 | Zeposia | $14 |
| Biogen | Meals · 2025-04-17 | Vumerity | $27 |
| Biogen | Meals · 2025-04-11 | Skyclarys | $29 |
| MDD US Operations | Meals · 2025-04-08 | None | $22 |
| SK Life Science | Meals · 2025-04-08 | None | $27 |
| Vanda Pharmaceuticals | Meals · 2025-04-01 | Ponvory | $33 |
| Biogen | Meals · 2025-03-31 | Vumerity | $8 |
| Catalyst Pharmaceuticals | Meals · 2025-03-31 | Fycompa | $16 |
| Lundbeck | Meals · 2025-03-28 | Vyepti | $28 |
| Amneal Pharmaceuticals | Meals · 2025-03-26 | Rytary | $28 |
| Catalyst Pharmaceuticals | Meals · 2025-03-24 | Fycompa | $36 |
| Catalyst Pharmaceuticals | Meals · 2025-03-24 | Fycompa | $2 |
| Lundbeck | Meals · 2025-03-22 | Rexulti | $29 |
| Celgene | Meals · 2025-03-19 | Zeposia | $20 |
| Lilly USA | Meals · 2025-03-19 | Kisunla | $18 |
| Novartis Pharmaceuticals | Meals · 2025-03-19 | Kesimpta | $13 |
| Abbvie | Meals · 2025-03-19 | Qulipta | $22 |
| Harmony Biosciences | Meals · 2025-03-14 | Wakix | $33 |
| Biogen | Meals · 2025-03-13 | Skyclarys | $30 |
| Catalyst Pharmaceuticals | Meals · 2025-03-11 | Fycompa | $43 |
| Octapharma USA | Meals · 2025-03-07 | Fibryga | $17 |
| Abbvie | Meals · 2025-02-26 | Ubrelvy | $12 |
| Alexion Pharmaceuticals | Meals · 2025-02-25 | Ultomiris | $29 |
| MDD US Operations | Meals · 2025-02-15 | None | $16 |
| Biogen | Meals · 2025-02-14 | Vumerity | $10 |
| Eisai | Meals · 2025-02-13 | Leqembi | $23 |
| Lilly USA | Meals · 2025-02-12 | Kisunla | $26 |
| Neurelis | Meals · 2025-02-12 | Valtoco | $43 |
| Catalyst Pharmaceuticals | Meals · 2025-02-10 | Fycompa | $24 |
| Catalyst Pharmaceuticals | Meals · 2025-02-10 | Fycompa | $9 |
| SK Life Science | Meals · 2025-02-05 | None | $35 |
| Surgenex | Meals · 2025-02-05 | Surgraft | $14 |
| Catalyst Pharmaceuticals | Meals · 2025-02-03 | Fycompa | $10 |
| Catalyst Pharmaceuticals | Meals · 2025-02-03 | Fycompa | $15 |
| Alexion Pharmaceuticals | Meals · 2025-01-31 | Ultomiris | $34 |
| Alexion Pharmaceuticals | Meals · 2025-01-29 | Ultomiris | $27 |
| SK Life Science | Meals · 2025-01-28 | None | $20 |
| Lilly USA | Meals · 2025-01-23 | Kisunla | $24 |
| Amgen | Meals · 2025-01-22 | Uplizna | $33 |
| Neurelis | Meals · 2025-01-21 | Valtoco | $36 |
| MDD US Operations | Meals · 2025-01-18 | None | $20 |
| Genentech USA | Meals · 2025-01-15 | Ocrevus | $26 |
| Lundbeck | Meals · 2025-01-15 | Vyepti | $27 |
| Alexion Pharmaceuticals | Meals · 2025-01-08 | Ultomiris | $33 |
| ANI Pharmaceuticals | Meals · 2025-01-08 | Purified Cortrophin Gel | $30 |
| Abbvie | Meals · 2025-01-06 | Ubrelvy | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,662
| Catalyst Pharmaceuticals | Fycompa | $406 | 23 payments
|
| EMD Serono | Mavenclad | $387 | 8 payments
|
| Novartis Pharmaceuticals | Kesimpta | $376 | 13 payments
|
| Abbvie | Qulipta | $289 | 13 payments
|
| Celgene | Zeposia | $202 | 10 payments
|
| Alexion Pharmaceuticals | Ultomiris | $178 | 7 payments
|
| Neurelis | Valtoco | $175 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Andexxa | $168 | 3 payments
|
| Biogen | Skyclarys | $143 | 7 payments
|
| Ucb | Briviact | $143 | 6 payments
|
| Eisai | Leqembi | $113 | 5 payments
|
| SK Life Science | None | $112 | 5 payments
|
| Chiesi USA | Cleviprex | $111 | 1 payment
|
| Lundbeck | Rexulti | $103 | 4 payments
|
| Lilly USA | Amyvid | $100 | 4 payments
|
| Kyowa Kirin | Nourianz | $91 | 4 payments
|
| Banner Life Sciences | Bafiertam | $90 | 4 payments
|
| Sumitomo Pharma America | Aptiom | $47 | 2 payments
|
| MDD US Operations | Apokyn | $47 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $46 | 2 payments
|
| Boston Scientific | Watchman Flx | $45 | 2 payments
|
| Merz Pharmaceuticals | None | $36 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $32 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $31 | 1 payment
|
| Amgen | Uplizna | $30 | 1 payment
|
| Harmony Biosciences | Wakix | $29 | 1 payment
|
| Argenx US | Vyvgart Hytrulo | $26 | 1 payment
|
| Pfizer | Nurtec Odt | $24 | 1 payment
|
| Octapharma USA | Panzyga | $22 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $16 | 1 payment
|
| Genentech USA | Ocrevus | $16 | 1 payment
|
| Acorda Therapeutics | Inbrija | $14 | 1 payment
|
| Ceribell | Pocket Eeg Device | $14 | 1 payment
|
2023: $3,606
| Biogen | Tysabri | $517 | 20 payments
|
| AbbVie | Qulipta | $276 | 9 payments
|
| Horizon Therapeutics plc | Uplizna | $234 | 6 payments
|
| SK Life Science | None | $226 | 11 payments
|
| Catalyst Pharmaceuticals | Fycompa | $221 | 15 payments
|
| Alexion Pharmaceuticals | Ultomiris | $190 | 4 payments
|
| Otsuka America Pharmaceutical | Rexulti | $188 | 5 payments
|
| Harmony Biosciences | Wakix | $183 | 4 payments
|
| Sumitomo Pharma America | Aptiom | $177 | 8 payments
|
| Acorda Therapeutics | Inbrija | $153 | 11 payments
|
| Ucb | Briviact | $117 | 4 payments
|
| Lundbeck | Vyepti | $111 | 4 payments
|
| Neurelis | Valtoco | $97 | 3 payments
|
| Novartis Pharmaceuticals | Kesimpta | $96 | 4 payments
|
| Celgene | Zeposia | $95 | 5 payments
|
| Lilly USA | Amyvid | $89 | 6 payments
|
| Eisai | Fycompa | $82 | 4 payments
|
| Genentech USA | Enspryng | $74 | 3 payments
|
| EMD Serono | Mavenclad | $63 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $59 | 2 payments
|
| Amneal Pharmaceuticals | Rytary | $53 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $44 | 2 payments
|
| Genzyme | Aubagio | $43 | 2 payments
|
| Alnylam Pharmaceuticals | Onpattro | $41 | 2 payments
|
| Pfizer | Nurtec Odt | $40 | 2 payments
|
| Janssen Pharmaceuticals | Ponvory | $37 | 2 payments
|
| GE HealthCare | None | $34 | 1 payment
|
| MDD US Operations | None | $25 | 1 payment
|
| Scilex Pharmaceuticals | Elyxyb | $16 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $15 | 1 payment
|
| Kyowa Kirin | Nourianz | $13 | 1 payment
|
2022: $2,800
| Janssen Pharmaceuticals | Ponvory | $422 | 21 payments
|
| Alexion Pharmaceuticals | Soliris | $397 | 5 payments
|
| Biogen | Tysabri | $245 | 14 payments
|
| SK Life Science | None | $205 | 10 payments
|
| Abbvie | Ubrelvy | $204 | 6 payments
|
| Eisai | Fycompa | $180 | 11 payments
|
| Genzyme | Aubagio | $178 | 10 payments
|
| Kyowa Kirin | Nourianz | $149 | 3 payments
|
| Horizon Therapeutics plc | Uplizna | $109 | 6 payments
|
| Neurocrine Biosciences | Ongentys | $93 | 6 payments
|
| EMD Serono | None | $77 | 4 payments
|
| Lilly USA | Emgality | $67 | 4 payments
|
| Celgene | Zeposia | $65 | 4 payments
|
| Sunovion Pharmaceuticals | Kynmobi | $64 | 5 payments
|
| Harmony Biosciences | Wakix | $58 | 3 payments
|
| Neurelis | Valtoco | $52 | 2 payments
|
| Novartis Pharmaceuticals | Kesimpta | $40 | 3 payments
|
| Acorda Therapeutics | Inbrija | $34 | 2 payments
|
| Amneal Pharmaceuticals | Rytary | $27 | 1 payment
|
| Lundbeck | Vyepti | $27 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $21 | 1 payment
|
| Ultragenyx Pharmaceutical | None | $21 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $20 | 1 payment
|
| Exeltis USA | Purified Cortrophin Gel | $16 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $15 | 1 payment
|
| Banner Life Sciences | Bafiertam | $14 | 1 payment
|
2021: $2,993
| Eisai | Fycompa | $330 | 30 payments
|
| Biogen | Tysabri | $328 | 17 payments
|
| Teva Pharmaceuticals USA | Ajovy | $272 | 8 payments
|
| Ucb | Vimpat | $236 | 11 payments
|
| Alexion Pharmaceuticals | Soliris | $189 | 9 payments
|
| Janssen Pharmaceuticals | Ponvory | $165 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $149 | 9 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $132 | 7 payments
|
| AbbVie | Ubrelvy | $127 | 9 payments
|
| SK Life Science | None | $124 | 7 payments
|
| Horizon Therapeutics plc | Uplizna | $101 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $98 | 5 payments
|
| Harmony Biosciences | Wakix | $93 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $93 | 4 payments
|
| Lundbeck | Vyepti | $70 | 4 payments
|
| Sanofi-Aventis U.S. | Aubagio | $55 | 3 payments
|
| Kyowa Kirin | Nourianz | $50 | 3 payments
|
| EMD Serono | None | $47 | 2 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $39 | 2 payments
|
| Banner Life Sciences | Bafiertam | $35 | 2 payments
|
| Alfasigma USA | None | $32 | 1 payment
|
| Celgene | Zeposia | $30 | 2 payments
|
| Adamas Pharmaceuticals | Gocovri | $28 | 2 payments
|
| Amgen | Repatha | $24 | 1 payment
|
| Genentech USA | Ocrevus | $24 | 1 payment
|
| Ge Healthcare | None | $23 | 1 payment
|
| Supernus Pharmaceuticals | Trokendi Xr | $19 | 1 payment
|
| Chiesi USA | Cleviprex | $18 | 1 payment
|
| Electromed | Smartvest | $18 | 1 payment
|
| Genzyme | Aubagio | $16 | 1 payment
|
| Arbor Pharmaceuticals | Horizant | $15 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $15 | 1 payment
|
2020: $1,715
| Portola Pharmaceuticals | Andexxa | $190 | 2 payments
|
| Eisai | Fycompa | $169 | 9 payments
|
| Alexion Pharmaceuticals | Soliris | $162 | 7 payments
|
| Biogen | Tysabri | $127 | 7 payments
|
| EMD Serono | Mavenclad | $126 | 8 payments
|
| Avanir Pharmaceuticals | Nuedexta | $104 | 5 payments
|
| SK Life Science | None | $97 | 4 payments
|
| Ucb | Briviact | $79 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $72 | 3 payments
|
| Kyowa Kirin | Nourianz | $62 | 4 payments
|
| US WorldMeds | Xadago | $62 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $56 | 3 payments
|
| Supernus Pharmaceuticals | Trokendi Xr | $54 | 3 payments
|
| Allergan | Ubrelvy | $46 | 2 payments
|
| Lilly USA | Emgality | $45 | 2 payments
|
| Novartis Pharmaceuticals | Kesimpta | $45 | 2 payments
|
| Alfasigma USA | None | $30 | 1 payment
|
| Akcea Therapeutics | Tegsedi | $29 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $29 | 1 payment
|
| LivaNova USA | Vns Therapy | $28 | 1 payment
|
| Genzyme | Aubagio | $22 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $22 | 1 payment
|
| Genentech USA | Ocrevus | $18 | 1 payment
|
| Chiesi USA | Cleviprex 50mg/100ml | $17 | 1 payment
|
| Upsher-Smith Laboratories | Tosymra Sumatriptan Nasal Spray | $13 | 1 payment
|
| Assertio Therapeutics | Cambia | $12 | 1 payment
|
2019: $6,703
| Medtronic Vascular | Reveal Linq | $3,285 | 8 payments
|
| Novartis Pharmaceuticals | Mayzent | $608 | 10 payments
|
| Alexion Pharmaceuticals | Soliris | $311 | 11 payments
|
| Biogen | Tecfidera | $291 | 12 payments
|
| Eisai | Fycompa | $274 | 12 payments
|
| Portola Pharmaceuticals | Andexxa | $235 | 6 payments
|
| Ucb | Briviact | $212 | 10 payments
|
| EMD Serono | Mavenclad | $192 | 9 payments
|
| Genzyme | Aubagio | $152 | 7 payments
|
| Genentech USA | Ocrevus | $136 | 7 payments
|
| Biotronik | None | $125 | 1 payment
|
| Supernus Pharmaceuticals | Oxtellar Xr | $116 | 15 payments
|
| CSL Behring | Hizentra | $78 | 4 payments
|
| Adamas Pharmaceuticals | Gocovri | $77 | 3 payments
|
| Akcea Therapeutics | Tegsedi | $66 | 1 payment
|
| Amgen | Aimovig | $54 | 2 payments
|
| Vertical Pharmaceuticals | Osmolex Er | $53 | 3 payments
|
| US WorldMeds | Xadago | $50 | 3 payments
|
| Sunovion Pharmaceuticals | Aptiom | $47 | 6 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $41 | 2 payments
|
| Lundbeck | Northera | $41 | 2 payments
|
| Amneal Pharmaceuticals | Rytary | $33 | 2 payments
|
| Merz North America | Xeomin | $33 | 1 payment
|
| Catalyst Pharmaceuticals | Firdapse | $30 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $29 | 1 payment
|
| Bausch Health US | Migranal | $29 | 2 payments
|
| Mallinckrodt Enterprises | Acthar | $24 | 1 payment
|
| Pfizer | Lyrica | $21 | 1 payment
|
| Chiesi USA | Cleviprex | $17 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $16 | 1 payment
|
| Lilly USA | Emgality | $14 | 1 payment
|
| Mitsubishi Tanabe Pharma America | Radicava | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 19.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1023076361
- Licence
- CA A32130California A32130: Current · expires 2028-01-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 2516 Samaritan Dr Ste E, San Jose, CA, 95124
- NPI first listed
- 2006-05-03
- NPI last updated
- 2021-04-21
- NPI record certified
- 2021-04-14
This is when the NPI record was last certified, not a medical board exam.